Throughout their lifecycle, women face various gynaecological challenges, ranging from pelvic pain to menopause. These issues impact physical and mental wellbeing, and health-related quality of life (QoL). Endometriosis, for example, affects 10% of women, causing debilitating pelvic pain and depression, whilst menopause encompasses 40+ symptoms, including anxiety and poor sleep. Optimal health outcomes require holistic, multidisciplinary support and careful symptom monitoring - however, this is expensive and rarely delivered, creating an opportunity for a cost-effective solution. At £1.8Billion, the UK market opportunity is large, and growing 15.38% CAGR. This project delivers a patient-facing mobile application that provides holistic, digital therapeutic support for common gynaecological conditions. Targeting women aged 18-65, our first use-cases are chronic pelvic pain and peri-/menopause. We reach end users through partnerships with GP practices. Our application will utilise a conversational interface to evaluate user needs across various dimensions, curate a personalised programme addressing key priorities (e.g. sleep, mood, pain), then guide the user through this 12-week digitised programme, with daily reminders and in-app activities. The app will collect patient-reported outcome measures, offering real-time feedback and enabling GPs to monitor patients remotely. This project takes our product from Technology Readiness Level (TRL) 4 to TRL 6\. This is a revolutionary approach to managing the multi-faceted nature of gynaecological health. Current solutions track the menstrual cycle only, and fail to meaningfully relay information back to providers. Our solution enables granular, real-time tracking of important gynaecological health outcomes; it optimises information exchange between patient and provider and facilitates remote monitoring. For individual women the impact will be improved wellbeing and QoL. 24% of women's work absenteeism is due to gynaecological health, costing the economy £20.2Billion/year. Our project addresses this societal problem by reducing work absence, and increasing productivity. It helps GPs manage women locally, thus easing NHS burden, and addresses health inequality by increasing accessibility for underserved populations. Following the award, we will develop and test the consumer application, integrate it with our existing operator dashboard, and disseminate it across a broad patient population. We have three practices ready to test, and will use outcome data to evidence ROI, aiming to convert pilots to paid contracts. Our vision is to become the gold-standard platform that partners with healthcare providers globally to offer holistic, digitised gynaecological support. In doing so, we wish to meaningfully address gender health inequity, foster sustainable change, improve wellbeing, and create a more equitable world for women.

Throughout their lifecycle, women face various gynaecological challenges ranging from heavy bleeding to Polycystic Ovary Syndrome (PCOS) and menopause. However, understanding and diagnosing these conditions is a long, arduous and fragmented process with delayed care and frequent misdiagnosis. This significantly affects women's quality of life, mental well-being, and ability to work. Insufficient public research funding widens the information gap, leaving women feeling neglected and disempowered. Bloomful is developing Lana, a unique solution harnessing conditional logic and AI-powered clinical reasoning. Lana enables self-triage of gynaecological symptoms, offering diagnostic predictions, decision support, and predictive forecasting and analytics. It then uses data from multiple sources to propose individual care plans. This solution builds upon an initial prototype tested by over 30,000 women, through which we identified the typical user profile and the most common symptoms reported. This prototype highlighted the need for a clinically robust screening tool encompassing a broad range of possible conditions and offering immediate clinical support. This project brings an entirely new solution to the market, with the potential to address some of the most pressing needs in healthcare. Bloomful primarily focuses on underserved communities and addresses women's health issues across the entire reproductive life cycle. With an addressable market of over $7 billion, we plan to reach individuals in the UK and the US first, whilst other potential geographies to explore include the Middle East and India. Our product will primarily be distributed through employers, both directly and via health insurance providers. The potential impact of Lana is substantial: implementing this tool could reduce diagnosis times, secondary care referrals and other interactions within the healthcare system - thus lowering NHS costs. Lana offers faster access to validated health information and services, improved health outcomes, and significant research contributions through organised data collection. The project aligns with the aims of the government's Women's Health Strategy to improve access to timely, personalised gynaecological care. Initial angel and grant funding has enabled Bloomful to develop a prototype of Lana, conduct market research and engage users. Further funding is crucial to advance R&D, achieve regulatory approval and ensure successful commercialisation of this pioneering solution.